Answers are grounded in this paper and cite their sources.
Thyrotropin-releasing hormone (TRH) added to whole blood in vitro before radioimmunoassay (RIA) is largely (more than 75%) inactivated in the time taken to separate the plasma from the cells. Addition of a peptidase inhibitor, benzamidine, in a final concentration of 50 mM or more prevents this. It is recommended that blood samples for RIA of TRH be collected in cooled syringes containing 100 μ1 of 2 M benzamidine per 3 ml of blood and that the plasma is separated within 15 minutes and extracted or assayed within 1 hour.
No takes yet. Share an insight, caveat, or question.
Jeffcoate et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: